Last reviewed 01/2018

Indications include:

  • malignant disease:
    • palliation
    • cure
  • adjuvant therapy to prevent recurrence
  • maintenance treatment to maintain remission
  • neoadjuvant therapy:
    • reduction in tumour bulk prior to other treatment modalities
    • predicts tumour sensitivity
  • cancer prevention:
    • populations at high risk e.g. tamoxifen for healthy women with a strong family history of breast cancer
    • currently controversial and under trial
  • non-malignant conditions e.g. immunosuppressive therapy for organ transplantation